The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/bcr1006.pdf
Reference28 articles.
1. Frame MC: Newest findings on the oldest oncogene; how activated Src does it. J Cell Sci. 2004, 117: 989-998. 10.1242/jcs.01111.
2. Bretscher A, Edwards K, Fehon RG: ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol. 2002, 3: 586-599. 10.1038/nrm882.
3. Gautreau A, Louvard D, Arpin M: ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol. 2002, 14: 104-109. 10.1016/S0955-0674(01)00300-3.
4. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M: Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell. 2003, 14: 2181-2191. 10.1091/mbc.E02-07-0410.
5. Gautreau A, Poullet P, Louvard D, Arpin M: Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA. 1999, 96: 7300-7305. 10.1073/pnas.96.13.7300.
Cited by 175 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunohistochemical expression of Parathyroid hormone-related protein and Ezrin in Invasive Breast Carcinoma of No Special Type: A retrospective Analysis;2024-08-16
2. The G protein-coupled receptor TBXA2R activates ERMs to promote motility, invasion, and metastasis of triple-negative breast cancer cells;2023-03-29
3. Perspectives for Targeting Ezrin in Cancer Development and Progression;Future Pharmacology;2023-01-09
4. Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis;Cancer Research Communications;2022-06-17
5. Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin;International Journal of Molecular Sciences;2022-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3